CPIG
MCRB icon

Chicago Partners Investment Group’s Seres Therapeutics MCRB Stock Holding History

Chicago Partners Investment Group’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5
Closed -$1K – 573
2016
Q4 		$1K Hold
5
– – ﹤0.01% 524
2016
Q3 		$1K Hold
5
– – ﹤0.01% 487
2016
Q2 		$3K Hold
5
– – ﹤0.01% 419
2016
Q1 		$3K Hold
5
– – ﹤0.01% 406
2015
Q4 		$4K Hold
5
– – ﹤0.01% 456
2015
Q3 		$3K Hold
5
– – ﹤0.01% 406
2015
Q2 		$4K Buy
+5
New +$4.36K ﹤0.01% 413

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Chicago Partners Investment Group's MCRB Position: Q1 2017 in Review

Chicago Partners Investment Group sold out of Seres Therapeutics (MCRB) in Q1 2017, closing a stake of 5 shares — an estimated $1K sold.

Chicago Partners Investment Group first reported a position in MCRB in Q2 2015 and held it in 7 quarters. The position peaked at $4K in Q4 2015. 79 funds tracked by Wall St. Rank hold MCRB as of Q1 2017.

  • Chicago Partners Investment Group reported no remaining Seres Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Chicago Partners Investment Group sold 5 Seres Therapeutics shares in Q1 2017, an estimated $1K.
  • Chicago Partners Investment Group first reported a position in Seres Therapeutics in Q2 2015 and held it in 7 quarters.
  • Chicago Partners Investment Group's Seres Therapeutics position peaked at $4K in Q4 2015.
  • 79 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2017.

Based on Chicago Partners Investment Group's 13F filing for Q1 2017, filed 11 May 2017.